Director of Clinical Development
EARLY CLINICAL DEVELOPMENT
Pulmocide
United Kingdom
Dr Lindsey Cass was previously Director, Clinical Development at Respivert and GSK and has extensive experience in the Early Phase Clinical Development of inhaled molecules.
Early Phase Clinical Development of inhaled molecules.